Eli Lilly plans $3.5 billion plant in Pennsylvania for obesity drugs
Eli Lilly Chairman and CEO Dave Ricks speaks during a news conference in Houston, Sept. 23, 2025. Antranik Tavitian |…
health care industry
15 drugs added to Medicare price negotiations
Boxes of the drug Trulicity, manufactured by Eli Lilly and Company, sit on a pharmacy counter in Provo, Utah, on…
Danaher Stock Fails to Rise on Strong Earnings, Leaving Us to Wonder What's Next
Danaher shares fell Wednesday as Wall Street failed to give the supplier of tools and equipment to drugmakers and hospitals…
UnitedHealth Group (UNH) Earnings in Q4 2025
UnitedHealth Group Inc. signs on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Wednesday,…
Amazon launches AI healthcare tool for One Medical members
Dr. Stephanie Long (right), MD, of One Medical Group, takes the blood pressure of Danielle Greene (left), who is 20…
Structure Therapeutics CEO talks obesity pill and more
Ray Stevens, CEO of Structure Therapeutics Inc., during a Bloomberg Television interview at the JPMorgan Healthcare Conference in San Francisco,…
OpenEvidence, 'ChatGPT for doctors', doubles its valuation to $12 billion
A startup widely known as “ChatGPT for doctors” raised a new round of funding that values the company at $12…
Another Alliance Between Healthcare and AI Indicates Why Pharma Stocks Could Make a Comeback
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating the early detection of lung cancer marks the latest way…
Novo Nordisk and Pfizer executives weigh in
US President Donald Trump arrives to make an announcement in the Roosevelt Room of the White House in Washington, DC,…
Keeping US biotech ahead of China could help patients with rare diseases: experts
The growth of China's biotech sector has been astonishing. Beijing is pumping money into the industry, supporting research efforts and…